Nature Index figures for 2021-2025 show global biomedical-engineering output growing 70%, faster than the database overall, with the field's share of all tracked papers rising from 2.4% to 2.7%. China's contribution to that output jumped from 28.9% to 50.9%, while the US and Germany held second and third place with roughly steady shares. The analysis also highlights South Korea, Switzerland, Canada and the Netherlands as countries with distinct patterns of specialization, growth or international collaboration in the field.
nature.com
· 2026-10-14
Nature released tables for its 2026 Spotlight on infectious diseases, built from the Nature Index database and covering articles published between 2021 and 2025. The dataset was compiled by running a keyword search across 83 infectious diseases, plus five subcategories for coronaviruses and influenza strains, within Digital Science's Dimensions database, then cross-referencing results against Nature Index entries.
nature.com
· 2026-10-07
An analysis by researchers including the article's author found that women make up around 41% of participants in cardiovascular disease clinical trials generally, but only 18-20% in regenerative-medicine trials for the same condition. Self-identified non-binary people were largely absent from these studies, according to the 2021 analysis.
nature.com
· 2026-09-23
Nature Index analysis covering 2016-2025 ranks the United States first and China second among the top 10 countries by research Share in regenerative medicine. The data also identifies institutions with the highest proportion of output devoted to the field, led by the University of Cincinnati, and highlights the strongest bilateral country collaborations in the area over the same period.
nature.com
· 2026-09-23
GoKawiil